Approxima is an early-stage MedTech company developing a minimally invasive device for the treatment of tricuspid valve regurgitation, a serious heart condition with limited therapeutic options. The company’s technology focuses on percutaneous right ventricular reshaping, enabling a physiological repair of the valve through a catheter-based procedure instead of open-heart surgery. By targeting the root cause of the disease, Approxima aims to provide a safer and more accessible solution for high-risk patients who are often ineligible for traditional surgical interventions.

Inoko Vision is a Polish MedTech company developing a non-invasive optical device (NeuroFET) that tracks retinal eye movements to assess the neurological state of the brain. Its technology enables early screening and monitoring of neurodegenerative diseases such as Alzheimer’s and Parkinson’s by using eye movement as an objective biomarker. By combining advanced retinal imaging, eye-tracking, and proprietary data analysis, the company aims to provide scalable, clinically useful tools for early diagnosis and longitudinal brain health monitoring.